title: Revascularization for patients with idiopathic thrombocytopenic purpura and coronary artery disease.
abstract: Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder with a low platelet count characterized by premature platelet destruction and suppression of platelet production mediated by autoantibodies, which may predispose to bleeding. Although the prevalence of coronary artery disease (CAD) in ITP seems to be rare, their co-occurrence is not unusual. Patients with ITP have increased risks for thrombosis and atherosclerosis associated with hemostatic factors, endothelial damage, and the negative effects of steroid and immunoglobulin therapies. Thus, the coexistence of ITP and CAD presents complex problems requiring a balance between hemorrhagic risk and prevention of thrombosis. Here, the authors present two patients with ITP, who were revascularized in different ways for CAD. Although the optimal management of thrombocytopenic patients with CAD is uncertain, individualized treatment modalities can be useful in patients with ITP and CAD.
authors.affiliation: Division of Cardiology, Yeungnam University Medical Center, Daegu, Korea.
authors.forename: Chan-Hee
authors.initials: CH
authors.lastname: Lee
authors.affiliation: Division of Cardiology, Yeungnam University Medical Center, Daegu, Korea.
authors.forename: Ung
authors.initials: U
authors.lastname: Kim
keywords: Coronary artery disease; Idiopathic thrombocytopenic purpura; Myocardial revascularization
references.citation: Int J Cardiol. 2008 Nov 28;130(3):e96-7
references.pmid: 17854925
references.citation: J Clin Pathol. 2006 Feb;59(2):146-9
references.pmid: 16443728
references.citation: J Thorac Cardiovasc Surg. 2003 Mar;125(3):554-8
references.pmid: 12658197
references.citation: Am J Med Sci. 2002 May;323(5):279-80
references.pmid: 12018673
references.citation: J Chin Med Assoc. 2006 Sep;69(9):436-8
references.pmid: 17051755
references.citation: Ann Thorac Surg. 2004 May;77(5):1819-21
references.pmid: 15111197
references.citation: J Invasive Cardiol. 2000 Jul;12(7):365-8
references.pmid: 10904444
references.citation: Ann Thorac Surg. 1997 Oct;64(4):1059-62
references.pmid: 9354527
references.citation: Blood. 2009 Jun 25;113(26):6511-21
references.pmid: 19395674
references.citation: J Am Coll Cardiol. 2004 Jul 21;44(2):349-56
references.pmid: 15261930
references.citation: N Engl J Med. 2002 Mar 28;346(13):995-1008
references.pmid: 11919310
references.citation: Catheter Cardiovasc Interv. 2003 Mar;58(3):285-91
references.pmid: 12594688
references.citation: Can J Cardiol. 1997 Aug;13(8):775-7
references.pmid: 9284845
references.citation: Ann Rheum Dis. 2000 Jan;59(1):77-80
references.pmid: 10627434
references.citation: Blood Coagul Fibrinolysis. 1999 Oct;10(7):439-42
references.pmid: 10695771
references.citation: Herz. 2010 Jan;35(1):43-9
references.pmid: 20140789
references.citation: Clin Neuropharmacol. 1997 Oct;20(5):385-93
references.pmid: 9331514
references.citation: Interact Cardiovasc Thorac Surg. 2011 Aug;13(2):153-7
references.pmid: 21576275
references.citation: J Thorac Cardiovasc Surg. 2001 Apr;121(4):689-96
references.pmid: 11279409